Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging

Show simple item record

dc.contributor.author Ebenhan, Thomas
dc.contributor.author Zeevaart, Jan Rijn
dc.contributor.author Venter, Jacobus D.
dc.contributor.author Govender, Thavendran
dc.contributor.author Kruger, Gert H.
dc.contributor.author Jarvis, Neil V.
dc.contributor.author Sathekge, Mike Machaba
dc.date.accessioned 2014-08-19T08:47:02Z
dc.date.available 2014-08-19T08:47:02Z
dc.date.issued 2014-02
dc.description.abstract Antimicrobial peptides such as ubiquicidin (UBI) are believed to differentiate between mammalian and bacterial or fungal cells. (99m)Tc-UBI29-41 was previously tested for detecting infection in humans using SPECT. For the present study, the UBI fragment UBI29-41 (TGRAKRRMQYNRR) was conjugated to 1,4,7-triazacyclononane-triacetic acid (NOTA), radiolabeled with (68)Ga, and investigated in a rabbit infection model. METHODS : (68)Ga was obtained from a 1.85-GBq (68)Ge/(68)Ga generator. New Zealand White rabbits were anesthetized with ketamine/medetomidine before tracer administration and placed in a clinical PET/CT scanner. (68)Ga-1,4,7-triazacyclononane-1,4,7-triacetic-acid-ubiquicidin29-41 ((68)Ga-NOTA-UBI29-41) was formulated in saline solution, and 101 ± 41 MBq were administered intravenously. The tracer distribution was studied by PET/CT imaging in animals (a) that were healthy, (b) bearing muscular Staphylococcus aureus infections and turpentine oil-induced muscular inflammations, and (c) bearing ovalbumin-induced lung inflammations. Static PET/CT imaging was performed at different time intervals up to 120 min after injection. For calculation of target-to-nontarget ratios, standardized uptake values were normalized against healthy thigh muscle, representing nontargeted tissue. RESULTS : PET/CT images of healthy animals showed predominant distribution in the kidneys, liver, and bladder; heart and spleen showed moderate, declining uptake, only. The biologic half-life in blood was 29 min. Urinary accumulation of (68)Ga-NOTA-UBI29-41 peaked at 3.8 ± 0.91 percentage injected dose per gram (%ID) at 120 min, and 88 ± 5.2 %ID was recovered in total urine. (68)Ga-NOTA-UBI29-41 imaging in (b) selectively visualized the muscular infection site and was differentiated from sterile inflammatory processes. Standardized uptake value ratios for muscles (infected/inflamed) were 2.9 ± 0.93, 2.9 ± 0.50, 3.5 ± 0.86, and 3.8 ± 0.90 at 5, 30, 60, and 90 min after injection, respectively. Rabbit lungs with asthma showed insignificant uptake. CONCLUSION : (68)Ga-NOTA-UBI29-41 was strongly localized in bacteria-infected areas and minimally detected in a sterile inflammation area in rabbit muscles. The findings propose this compound to be an excellent first-line PET/CT tracer to allow the distinguishing of infection from inflammation. en_US
dc.description.librarian hb2014 en_US
dc.description.uri http://jnm.snmjournals.org/ en_US
dc.identifier.citation Ebenhan, T, Zeevaart, JR, Venter, JD, Govender, T, Kruger, GH, Jarvis, NV & Sathekge, MM 2014, 'Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging', Journal of Nuclear Medicine, vol. 55, no. 2, pp. 308-314. en_US
dc.identifier.issn 0161-5505 (print)
dc.identifier.issn 1535-5667 (online)
dc.identifier.other 10.2967/jnumed.113.128397
dc.identifier.uri http://hdl.handle.net/2263/41441
dc.language.iso en en_US
dc.publisher Society of Nuclear Medicine en_US
dc.rights © 2014 Society of Nuclear Medicine and Molecular Imaging. This research was originally published in Journal of Nuclear Medicine, Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging, Ebenhan, T, Zeevaart, JR, Venter, JD, Govender, T, Kruger, GH, Jarvis, NV & Sathekge, MM, vol. 55, no.2, pp. 308-314, doi : 10.2967/jnumed.113.128397. en_US
dc.subject 68Ga labeling en_US
dc.subject PET/CT en_US
dc.subject UBI29-41 en_US
dc.subject Infection en_US
dc.subject Ubiquicidin en_US
dc.subject Computerized tomography (CT)
dc.subject Positron emission tomography (PET)
dc.title Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging en_US
dc.type Postprint Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record